FDA flags misleading claims for cancer drug by biotech billionaire Patrick Soon-Shiong

abcnews - Federal health officials have issued a warning about controversial statements made by biotech billionaire Dr. Patrick Soon-Shiong about one of his company's cancer drugs

AI Summary: The FDA issued warnings over promotional materials and public statements related to a cancer drug associated with a biotech entrepreneur, finding claims that could mislead patients and investors. The agency asked the company to correct materials and refrain from unsubstantiated efficacy or safety assertions while oversight and compliance reviews continue.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

VOLGA Phase III shows survival benefit for bladder cancer neoadjuvant combo / 15 days

Datroway secures regulatory approvals in breast cancer across US and EU / 8 days

FDA clears first targeted therapy for ultra-rare NRG1-driven cholangiocarcinoma / 20 days

FDA grants early access to experimental pancreatic cancer drug / 29 days

FDA approves relacorilant plus nab‑paclitaxel for resistant ovarian cancers / 7 wks

FDA clears pivekimab sunirine (Decnupaz) as first BPDCN ADC / 46 hrs

FDA to revisit Atara/Pierre Fabre cell therapy approval for rare lymphoma / 22 days